The Antibody Library Technology Market is expected to be worth US$ 100 Million at a CAGR of 4.4% between 2024. Healthcare is going the “digital” way. In other words, artificial intelligence (AI)-enabled medical devices and telemedicine are the concrete instances of the proliferation of the digital wave in the healthcare industry. This factor would be the one traversing the healthcare vertical in the forecast period.
Demand for antibody library technologies is expected to surge, as the arrival of advanced antibodies and their display technologies continue to reduce complexities of life science and biotechnology research.
Persistence Market Research (PMR), in its latest report, projects that the global antibody library technologies market revenue will increase at a CAGR of 4.4% between 2016 and 2024. Some of the latest antibody library design and selection methods enable easy identification of any MAB with any specificity, which is why pharmaceutical companies are increasingly making use of such technologies in their facilities.
Strategizing The Moves For The Next Decade? See Through Sample Of Antibody Library Technology Market Report! https://www.persistencemarketresearch.com/samples/11155
- MorphoSys AG
- Dyax Corp.
- Abzena Plc.
- XOMA Corporation
- AvantGen Inc.
- AbCheck s.r.o.
- Philogen S.p.A.
- Adimab LLC
- Invenra Inc.
- AnaptysBio, Inc.
- Abwiz Bio Inc.
- Abgent Inc. (WuXi AppTec company)
- Vaccinex Inc.
- AxioMx Inc.
“Owing to the limitation and shortcomings of the conventional molecular display technologies, biomedical research organizations are now shifting towards new age display less’ technologies, capable of isolating antibodies up to subnanomolar affinities.” – Analyst, Persistence Market Research
Global Antibody Library Technologies: Key Market Trends
As the market becomes more competitive, players aim to offer additional services complementary to antibody libraries.
Consolidation between technology developers and drug development organizations in order to increase the consumer base has been identified as a prominent trend in the global market for antibody library technologies.
Widespread adoption of cell-free display platform will persist throughout the forecast period, owing to the compact nature of such contemporary display platforms. For instance, the popularity of cell-free ribosome display technology has grown significantly amongst end-users in recent years.
Starting With The New Decade On A Diligent Note In The Antibody Library Technology Market? https://www.persistencemarketresearch.com/methodology/11155
Highlights of the Report Include
Phage display to remain as the predominant antibody library technology in 2017 and beyond. Moreover, constant technological advancement is expected to support its widespread adoption in the medium term. Phage display was the first in vitro technology developed for antibody selection and is extensively used by scientists all over the world. In 2016, sales revenue of phage display technology reached US$ 68.0 Million and is likely increase at 5% CAGR over 2024.
How About Obtaining Insights About The Region To Enter Concerning The Antibody Library Technology Market? Press The “Purchase Now” Button To Have Our Antibody Library Technology Market Report! https://www.persistencemarketresearch.com/checkout/11155
Based on application, antibody library technologies are primarily used in drug discovery programs. Nearly US$ 81.3 Million worth antibody library technologies were purchased for drug development purposes in 2016. Meanwhile, biopharmaceutical companies remain the major end users of such technologies and are expected to create an incremental opportunity of US$ 44.Mn between 2016 and 2026 for the market.
Amongst all the key regions, the antibody library technologies market in North America accounted for a massive revenue share of 57.5% in 2015.
This is primarily due to the favorable government initiatives for development of cost-effective monoclonal antibodies in the US, which is driving the demand for antibody library technologies in the region. North America will continue to be most lucrative market over the forecast period followed by Europe and APAC.
Access Related Reports:
Neuropathic Pain Management Market:
Reaching the revenues of over US$ 6 Bn at the end of 2019, the global neuropathic pain management market is projected for a healthy CAGR during the forecast period (2019 – 2029). Increasing prevalence of neuropathic pain disorders and growing awareness about pain medication are boosting the demand for pain management drugs.
Sterilization Services Market:
The global sterilization services market was valued at US$ 2.6 Bn in 2018, and is expected to witness a CAGR of over 7% during the forecast period (2019-2029).
Lateral Flow Assay Market:
According to the latest research by the company, the global lateral flow assay market is projected to account for over US$ 9.7 Bn in terms of value by the end of 2026. The report further projects a 5.4% growth rate with an increasing average Y-o-Y throughout 2026.
Syndesmosis Implant Systems Market:
Persistence Market Research predicts that the global syndesmosis implant systems market will exhibit an impressive 8% CAGR over the forecast period to reach a valuation of US$ 160 Mn by 2030.
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – firstname.lastname@example.org
Website – https://www.persistencemarketresearch.com